Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcome

Transplant Immunology

Volumn 30, Issue 2-3, 2014, Pages 59-64

  Joris M M ^a,b   Lankester, A C ^b   von dem Borne, P A ^b   Kuball, J ^c   Bierings, M ^d   Cornelissen, J J ^e   Groenendijk Sijnke, M E ^e   van der Holt, B ^e   van Rood, J J ^a,b   Oudshoorn, M ^a,b   Claas, F H J ^b  

^a Europdonor Foundation   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UMCU   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acute GVHD; Amino acid; CTLp; Hematopoietic stem cell transplantation; Mismatch score

Indexed keywords

ALEMTUZUMAB; CYCLOSPORIN A; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOIMMUNITY; ARTICLE; BONE MARROW DEPRESSION; CHILD; CHRONIC LEUKEMIA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG USE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IN VITRO STUDY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NETHERLANDS; PREDICTION; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; T CELL DEPLETION; AGE; ALLOGRAFT; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; IMMUNOLOGY; INFANT; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; PRESCHOOL CHILD; TRANSLATIONAL RESEARCH; UNRELATED DONORS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ALLOGRAFTS; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INFANT; MALE; MIDDLE AGED; NETHERLANDS; PREDICTIVE VALUE OF TESTS; TRANSLATIONAL MEDICAL RESEARCH; UNRELATED DONORS;

EID: 84896546995     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2013.08.006     Document Type: Article

References (16)

1. Jöris M.M., Van Rood J.J., Roelen D.L., Oudshoorn M., Claas F.H. A proposed algorithm predictive for cytotoxic T cell alloreactivity. J Immunol Feb 15 2012, 188(4):1868-1873.
2. Dolezalova L., Vrana M., Dobrovolna M., Loudova M., Cukrova V., Vitek A., et al. Cytotoxic T lymphocyte precursor frequency analysis in the selection of HLA matched unrelated donors for hematopoietic stem cell transplantation: the correlation of CTLp frequency with HLA class I genotyping and aGVHD development. Neoplasma 2002, 49(1):26-32.
3. Kaminski E., Hows J., Man S., Brookes P., Mackinnon S., Hughes T., et al. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation Oct 1989, 48(4):608-613.
4. Keever-Taylor C.A., Passweg J., Kawanishi Y., Casper J., Flomenberg N., Baxter-Lowe L.A. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation. Bone Marrow Transplant May 1997, 19(10):1001-1009.
5. Kircher B., Niederwieser D., Gachter A., Lindner B., Mitterschiffthaler A., Urban C., et al. T-cell precursor frequencies and long-term outcome following unrelated hematopoietic stem cell transplantation. Int J Lab Hematol Dec 2008, 30(6):499-507.
6. Kwok J.S., Leung A.Y., Lie A.K., Lee T.L., Lau Y.L., Chu P., et al. Antirecipient helper and cytotoxic T-cell frequencies in bone marrow transplantation. Bone Marrow Transplant Aug 2004, 34(3):207-213.
7. Spencer A., Brookes P.A., Kaminski E., Hows J.M., Szydlo R.M., RF van, et al. Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors. Value in donor selection. Transplantation May 15 1995, 59(9):1302-1308.
8. van der Meer A., Joosten I., Schattenberg A.V., de Witte T.J., Allebes W.A. Cytotoxic T-lymphocyte precursor frequency (CTLp-f) as a tool for distinguishing permissible from non-permissible class I mismatches in T-cell-depleted allogeneic bone marrow transplantation. Br J Haematol Nov 2000, 111(2):685-694.
9. Heemskerk M.B., Cornelissen J.J., Roelen D.L., Van Rood J.J., Claas F.H., Doxiadis I.I., et al. Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation. Bone Marrow Transplant Aug 2007, 40(3):193-200.
10. Roosnek E., Hogendijk S., Zawadynski S., Speiser D., Tiercy J.M., Helg C., et al. The frequency of pretransplant donor cytotoxic T cell precursors with anti-host specificity predicts survival of patients transplanted with bone marrow from donors other than HLA-identical siblings. Transplantation Sep 1993, 56(3):691-696.
11. Heemskerk M.B., Roelen D.L., Dankers M.K., Van Rood J.J., Claas F.H., Doxiadis I.I., et al. Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response. Hum Immunol Sep 2005, 66(9):969-976.
12. Oudshoorn M., Doxiadis I.I., van den Berg-Loonen P.M., Voorter C.E., Verduyn W., Claas F.H. Functional versus structural matching: can the CTLp test be replaced by HLA allele typing?. Hum Immunol Mar 2002, 63(3):176-184.
13. Robinson J., Mistry K., McWilliam H., Lopez R., Parham P., Marsh S.G. The IMGT/HLA database. Nucleic Acids Res Jan 2011, 39(Database issue):D1171-D1176.
14. Fine J.P., Gray R.J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc Jan 6 1999, 94:496-509. (446 (Jun., 1999)).
15. Kolb H.J. Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood Dec 1 2008, 112(12):4371-4383.
16. Shlomchik W.D. Graft-versus-host disease. Nat Rev Immunol May 2007, 7(5):340-352.